Abiomed Inc (ABMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ABMD | TMO | ISRG | EW | IDXX |
| Company | Abiomed Inc | Thermo Fisher Scientific Inc | Intuitive Surg Inc | Edwards Lifesciences Corp | Idexx Laboratories |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NYSE | NASDAQ |
| Open | 380.78 | 542.95 | 385.27 | 87.20 | 482.20 |
| High | 381.28 | 544.64 | 388.65 | 87.20 | 482.21 |
| Low | 380.51 | 539.17 | 365.00 | 85.50 | 473.62 |
| Last | 381.02 | 544.06 | 368.70 | 85.44 | 474.23 |
| Change | +0.23 | +2.54 | -3.93 | -1.01 | -3.56 |
| % Change | +0.06% | +0.47% | -1.05% | -1.17% | -0.75% |
| Volume | 20,612,200 | 443,045 | 1,818,320 | 1,060,309 | 147,263 |
| 20-Day Average Volume | 2,182,260 | 1,220,615 | 1,482,446 | 2,873,303 | 383,486 |
| Previous Close | 380.79 | 541.52 | 372.63 | 86.45 | 477.79 |
| Industry | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 379.15 | 569.39 | 386.20 | 91.69 | 511.91 |
| 20-Day Raw Stochastic | 85.14% | 23.60% | 6.05% | 0.48% | 2.73% |
| 20-Day Relative Strength | 74.25% | 38.55% | 40.25% | 40.88% | 27.01% |
| Weighted Alpha | 0.00 | -1.69 | +23.12 | +3.98 | -6.55 |
| Today's Opinion | 100% Buy | 24% Buy | 40% Buy | 56% Buy | 24% Sell |
| Previous Opinion | 100% Buy | 40% Buy | 56% Buy | 56% Buy | 24% Sell |
| Last Month's Opinion | 88% Buy | 88% Buy | 100% Buy | 88% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.24% since 12/14/22 | -3.78% since 04/12/24 | -4.54% since 04/12/24 | -5.04% since 04/12/24 | -4.47% since 04/12/24 |
| Low | 380.11 on 12/15/22 | 529.64 on 04/18/24 | 365.00 on 04/19/24 | 85.68 on 04/19/24 | 473.62 on 04/19/24 |
| High | 381.69 on 12/19/22 | 570.72 on 04/15/24 | 392.29 on 04/15/24 | 91.73 on 04/15/24 | 506.57 on 04/15/24 |
| 1-Month | |||||
| %Chg | +1.17% since 11/21/22 | -6.67% since 03/19/24 | -5.94% since 03/19/24 | -9.10% since 03/19/24 | -11.02% since 03/19/24 |
| Low | 376.55 on 12/02/22 | 529.64 on 04/18/24 | 365.00 on 04/19/24 | 85.68 on 04/19/24 | 473.62 on 04/19/24 |
| High | 381.80 on 12/08/22 | 589.93 on 04/09/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 543.33 on 03/28/24 |
| 3-Month | |||||
| %Chg | +50.71% since 09/21/22 | -1.43% since 01/19/24 | -1.99% since 01/19/24 | +15.37% since 01/19/24 | -9.22% since 01/19/24 |
| Low | 237.44 on 10/12/22 | 529.64 on 04/18/24 | 362.14 on 01/24/24 | 71.92 on 01/25/24 | 473.62 on 04/19/24 |
| High | 381.99 on 11/01/22 | 603.82 on 03/08/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 583.39 on 03/01/24 |
| 6-Month | |||||
| %Chg | +64.04% since 06/21/22 | +15.80% since 10/19/23 | +34.34% since 10/19/23 | +24.10% since 10/19/23 | +11.71% since 10/19/23 |
| Low | 227.02 on 06/22/22 | 415.60 on 10/25/23 | 254.85 on 10/30/23 | 60.57 on 10/30/23 | 372.50 on 11/01/23 |
| High | 381.99 on 11/01/22 | 603.82 on 03/08/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 583.39 on 03/01/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 17,180,568 | 206,705,760 | 132,078,328 | 52,036,584 | 39,682,372 |
| Shares Outstanding, K | 45,091 | 381,714 | 354,449 | 601,927 | 83,054 |
| Annual Sales | 1,031,750,000 | 42,857,000,000 | 7,124,100,000 | 6,004,800,000 | 3,660,950,000 |
| Annual Net Income | 136,510,000 | 5,995,000,000 | 1,798,000,000 | 1,402,400,000 | 845,040,000 |
| Last Quarter Sales | 265,920,000 | 10,886,000,000 | 1,928,300,000 | 1,534,100,000 | 901,600,000 |
| Last Quarter Net Income | 106,130,000 | 1,630,000,000 | 606,200,000 | 369,900,000 | 194,520,000 |
| 60-Month Beta | 1.40 | 0.80 | 1.36 | 1.05 | 1.26 |
| Per-Share Information | |||||
| Most Recent Earnings | 1.30 on 11/01/22 | 5.67 on 01/31/24 | 1.50 on 04/18/24 | 0.64 on 02/06/24 | 2.32 on 02/05/24 |
| Latest Earnings Date | 02/02/23 | 04/24/24 | 04/18/24 | 04/25/24 | 05/01/24 |
| Most Recent Dividend | N/A | 0.390 on 03/14/24 | N/A | N/A | N/A |
| Next Ex-Dividends Date | N/A | 03/14/24 | N/A | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 78.68 | 25.41 | 82.78 | 34.76 | 47.49 |